An Emerging Role of Pharmacist in Pre-chemotherapy Counselling among Breast Cancer Patients

被引:5
作者
Dang, C. C. [1 ]
Amiruddin, M. [1 ]
Lai, S. S. [1 ]
Low, C. F. [1 ]
Chan, S. Y. [2 ]
机构
[1] Gen Hosp Melaka, Dept Pharm, Jalan Mufti Haji Khalil, Melaka 75400, Malaysia
[2] Univ Sains Malaysia, Sch Pharmaceut Sci, Gelugor 11800, Penang, Malaysia
关键词
Pre-chemotherapy; counselling; breast cancer; pharmacist; RECEIVING CHEMOTHERAPY; SATISFACTION; INFORMATION; WOMEN; CARE; CONSULTATION; PREFERENCES; DIAGNOSIS; COUNTRIES; AWARENESS;
D O I
10.4172/pharmaceutical-sciences.1000228
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The understanding of adult patients receiving cancer chemotherapy of their regimen is important for better control of chemotherapy-related side effects. Often, patients forget, misunderstand or unsatisfied with the information received. The purpose of this study is to investigate the effectiveness of pharmacist-led pre-chemotherapy counselling on the knowledge of chemotherapy treated breast cancer patients. It is a randomized and prospective study where patients were randomly distributed into intervention group who received pharmacist-led pre-chemotherapy counselling and control group who did not receive pharmacist-led pre-chemotherapy counselling. Knowledge assessments and perception of the patients were carried out after pharmacist-led pre-chemotherapy counselling in both intervention and control group using a structured validated questionnaire. Overall, 38 out of 40 patients completed the study with a 97% response rate. Significant improvement in the understanding of chemotherapy regimen and its side-effects was observed in the intervention group as compared to the control group. Besides, patients counselled by pharmacists were able to recall back the information even at the sixth cycle of the chemotherapy regimen compared to the control group. Majority of the breast cancer patients agreed that pharmacist-led pre-chemotherapy counselling was effective. This study suggests that pharmacist-led pre-chemotherapy counselling improves patient knowledge and understanding of the chemotherapy regimen received.
引用
收藏
页码:294 / 302
页数:9
相关论文
共 50 条
  • [21] Determinants Affecting Quality of Life: Implications for Pharmacist Counseling for Patients with Breast Cancer in Japan
    Kawaguchi, Takashi
    Iwase, Satoru
    Koinuma, Masayoshi
    Onodera, Yuki
    Takeuchi, Hironori
    Umeda, Megumi
    Matsunaga, Tadaharu
    Unezaki, Sakae
    Nagumo, Yoshinori
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2012, 35 (01) : 59 - 64
  • [22] Health disparities among breast cancer patients with/without disabilities in Germany
    Gross, Sophie E.
    Pfaff, Holger
    Swora, Michael
    Ansmann, Lena
    Albert, Ute-Susann
    Gross-Kunkel, Anke
    DISABILITY AND HEALTH JOURNAL, 2020, 13 (02)
  • [23] The role of the clinical pharmacist in guiding adjuvant hormonal therapy in patients with breast cancer
    Pirolli, Amanda, V
    Brusamarello, Tatiana
    Everton, Stella S.
    Andrzejevski, Vania M. S.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (06) : 1368 - 1374
  • [24] Emerging role of brain metastases in the prognosis of breast cancer patients
    Hambrecht, Amanda
    Jandial, Rahul
    Neman, Josh
    BREAST CANCER-TARGETS AND THERAPY, 2011, 3 : 79 - 91
  • [25] Role of chemotherapy in breast cancer
    Hussain, Syed A.
    Palmer, Daniel H.
    Stevens, Andrea
    Spooner, David
    Poole, Christopher J.
    Rea, Daniel W.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (06) : 1095 - 1110
  • [26] Prayer-for-health and complementary alternative medicine use among Malaysian breast cancer patients during chemotherapy
    Chui, Ping Lei
    Abdullah, Khatijah Lim
    Wong, Li Ping
    Taib, Nur Aishah
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 14
  • [27] Consistency in paired comparisons of Information Needs Questionnaires (INQ) among Hong Kong Chinese breast cancer patients
    Choi, K. C.
    So, Winnie K. W.
    Li, Polly W. C.
    Lau, S. F.
    Lo, Joe C. K.
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2013, 17 (02) : 170 - 175
  • [28] Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancer
    Yuan, Yuan
    Vora, Nilesh
    Sun, Can-Lan
    Li, Daneng
    Soto-Perez-de-Celis, Enrique
    Mortimer, Joanne
    Luu, The-Hang
    Somlo, George
    Waisman, James
    Smith, David
    Chao, Joseph
    Katheria, Vani
    Synold, Timothy
    Tran, Vivi
    Mi, Shu
    Levi, Abrahm
    Arsenyan, Anait
    Choi, Jennifer
    Zavala, Laura
    Yost, Susan
    Hurria, Arti
    BREAST CANCER RESEARCH, 2017, 19
  • [29] The association between cancer-related fatigue and diabetes from pre-chemotherapy to 6 months post-chemotherapy
    Kleckner, Amber S.
    Kleckner, Ian R.
    Culakova, Eva
    Shayne, Michelle
    Belcher, Elizabeth K.
    Gudina, Abdi T.
    Williams, AnnaLynn M.
    Onitilo, Adedayo A.
    Hopkins, Judith O.
    Gross, Howard
    Mustian, Karen M.
    Peppone, Luke J.
    Janelsins, Michelle C.
    SUPPORTIVE CARE IN CANCER, 2022, 30 (09) : 7655 - 7663
  • [30] Risk of febrile neutropenia in patients receiving emerging chemotherapy regimens for breast cancer
    Gilbar, Peter
    Sorour, Natacha
    McPherson, Ian
    SUPPORTIVE CARE IN CANCER, 2015, 23 (03) : 619 - 620